Skip to content

Clinical trials

Phase 1/2 Parkinson Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 1/2 Country / region: United States Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20071
20082
20095
20101
20111
20123
20141
20173
20186
20192
20203
20211
20223
20232
20243
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Recruiting8
Active, not recruiting4
Terminated3
Not yet recruiting1
Enrolling by invitation1
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
MeiraGTx, LLC2
National Institute of Neurological Disorders and Stroke (NINDS)2
Prabesh Kanel2
State University of New York at Buffalo2
University of Florida2
VA Office of Research and Development2
Weill Medical College of Cornell University2
Amydis Inc.1
Annovis Bio Inc.1
Apeiron Research Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease49
Alzheimer Disease3
Amyotrophic Lateral Sclerosis2
Cough2
Dyskinesias2
Hypokinesia2
Movement Disorders2
Multiple System Atrophy2
Anxiety Disorders1
Autonomic Nervous System Diseases1

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.